Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Should a Toll-like receptor 4 (TLR-4) agonist or antagoni... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers
0
Authors
Mallikarjuna Pichika
2 more
Mallikarjuna Pichika
•
Chun Wu
•
Yew Kang
Published
November 1, 2013
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
OncoTargets and therapy
Topics
Medicine
Immunology
Microbiology
Internal Medicine
Cancer Research
Show all topics
DOI
10.2147/ott.s50838
License
CC-BY-NC
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
OncoTargets and therapy
Topics
Medicine
Immunology
Microbiology
Internal Medicine
Cancer Research
Show all topics
DOI
10.2147/ott.s50838
License
CC-BY-NC
Other Formats
PDF
